EUVIMEDEUVIMED entdecken
Systematische Übersicht

Cost-effectiveness of sofosbuvir- ledipasvir for Hepatitis C treatment: a systematic review

Nasim Jaberi, Somayeh Afshari, Farhad Khalili, Aziz Rezapour

European Journal of Clinical Pharmacology · 2026-04 · 82 (4)

DOI: 10.1007/s00228-026-04017-7 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 07.04.2026. Verfasst von Nasim Jaberi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Rashid Yasemi Street, Vali…. Hauptthemen laut MEDLINE: Fluorenes, Benzimidazoles, Antiviral Agents, Sofosbuvir. Die Arbeit nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluorenesBenzimidazolesAntiviral AgentsSofosbuvirHepatitis CHepatitis C, ChronicHumansCost-Benefit AnalysisCost-Effectiveness AnalysisDrug Combinations

Stichwörter der Autor:innen

Cost-effectiveness analysisEconomic evaluationHepatitis CSofosbuvir/LedipasvirSystematic review

Substanzen

FluorenesBenzimidazolesAntiviral AgentsSofosbuvirledipasvir, sofosbuvir drug combinationDrug Combinations

Autor:innen und Institutionen

  • Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Rashid Yasemi Street, Valiasr Street, Tehran, Iran.
  • Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Rashid Yasemi Street, Valiasr Street, Tehran, Iran. khalili56@yahoo.com.
  • Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Sciences, Rashid Yasemi Street, Valiasr Street, Tehran, Iran, 1996713883. rezapoor_a57@yahoo.com.

Zitieren

APA

Jaberi, N., Afshari, S., Khalili, F., & Rezapour, A. (2026). Cost-effectiveness of sofosbuvir- ledipasvir for Hepatitis C treatment: a systematic review. European Journal of Clinical Pharmacology, 82(4). https://doi.org/10.1007/s00228-026-04017-7

Vancouver

Jaberi N, Afshari S, Khalili F, Rezapour A. Cost-effectiveness of sofosbuvir- ledipasvir for Hepatitis C treatment: a systematic review. European Journal of Clinical Pharmacology. 2026;82(4). doi:10.1007/s00228-026-04017-7

BibTeX
@article{Jaberi2026,
  author = {Jaberi, Nasim and Afshari, Somayeh and Khalili, Farhad and Rezapour, Aziz},
  title = {Cost-effectiveness of sofosbuvir- ledipasvir for Hepatitis C treatment: a systematic review},
  journal = {European Journal of Clinical Pharmacology},
  year = {2026},
  volume = {82},
  number = {4},
  doi = {10.1007/s00228-026-04017-7}
}
Kostenlos starten →